MPS Pharmaa Limited (BOM:531686)

MPS Pharmaa Statistics

Total Valuation

MPS Pharmaa has a market cap or net worth of INR 32.11 million. The enterprise value is 107.12 million.

Market Cap	32.11M
Enterprise Value	107.12M

Important Dates

The next estimated earnings date is Monday, February 2, 2026.

Earnings Date	Feb 2, 2026
Ex-Dividend Date	n/a

Share Statistics

MPS Pharmaa has 19.11 million shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	19.11M
Shares Outstanding	19.11M
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	21.72%
Owned by Institutions (%)	1.06%
Float	5.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	73.44
PB Ratio	4.97
P/TBV Ratio	4.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.98
EV / Sales	245.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.48

Financial Position

The company has a current ratio of 0.25, with a Debt / Equity ratio of 11.63.

Current Ratio	0.25
Quick Ratio	0.00
Debt / Equity	11.63
Debt / EBITDA	n/a
Debt / FCF	-13.65
Interest Coverage	-900.31

Financial Efficiency

Return on equity (ROE) is -82.26% and return on invested capital (ROIC) is -10.36%.

Return on Equity (ROE)	-82.26%
Return on Assets (ROA)	-5.78%
Return on Invested Capital (ROIC)	-10.36%
Return on Capital Employed (ROCE)	-106.32%
Weighted Average Cost of Capital (WACC)	1.16%
Revenue Per Employee	24,289
Profits Per Employee	-496,944
Employee Count	18
Asset Turnover	0.00
Inventory Turnover	0.04

Taxes

In the past 12 months, MPS Pharmaa has paid 286,462 in taxes.

Income Tax	286,462
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.10% in the last 52 weeks. The beta is -0.08, so MPS Pharmaa's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-60.10%
50-Day Moving Average	2.59
200-Day Moving Average	2.47
Relative Strength Index (RSI)	23.98
Average Volume (20 Days)	2,179

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MPS Pharmaa had revenue of INR 437,204 and -8.94 million in losses. Loss per share was -0.47.

Revenue	437,204
Gross Profit	258,193
Operating Income	-8.64M
Pretax Income	-8.66M
Net Income	-8.94M
EBITDA	-7.18M
EBIT	-8.64M
Loss Per Share	-0.47

Balance Sheet

The company has 43,000 in cash and 75.06 million in debt, with a net cash position of -75.01 million or -3.92 per share.

Cash & Cash Equivalents	43,000
Total Debt	75.06M
Net Cash	-75.01M
Net Cash Per Share	-3.92
Equity (Book Value)	6.45M
Book Value Per Share	0.35
Working Capital	-61.12M

Cash Flow

In the last 12 months, operating cash flow was -6.03 million and capital expenditures 535,000, giving a free cash flow of -5.50 million.

Operating Cash Flow	-6.03M
Capital Expenditures	535,000
Free Cash Flow	-5.50M
FCF Per Share	-0.29

Margins

Gross Margin	59.06%
Operating Margin	-1,976.87%
Pretax Margin	-1,980.43%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MPS Pharmaa does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.41%
Shareholder Yield	-0.41%
Earnings Yield	-27.86%
FCF Yield	-17.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3